1 SARS-Cov-2 Test Kits Market Overview

• 1.1 Product Overview and Scope of SARS-Cov-2 Test Kits
• 1.2 SARS-Cov-2 Test Kits Segment by Type
• 1.2.1 Global SARS-Cov-2 Test Kits Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 IgM Test Kit

1.2.3 IgG Test Kit

1.3 SARS-Cov-2 Test Kits Segment by Application

1.3.1 Global SARS-Cov-2 Test Kits Sales Comparison by Application: (2022-2028)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Disease Control and Prevention System

1.4 Global SARS-Cov-2 Test Kits Market Size Estimates and Forecasts

1.4.1 Global SARS-Cov-2 Test Kits Revenue 2017-2028

1.4.2 Global SARS-Cov-2 Test Kits Sales 2017-2028

1.4.3 SARS-Cov-2 Test Kits Market Size by Region: 2017 Versus 2021 Versus 2028

2 SARS-Cov-2 Test Kits Market Competition by Manufacturers

• 2.1 Global SARS-Cov-2 Test Kits Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global SARS-Cov-2 Test Kits Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global SARS-Cov-2 Test Kits Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers SARS-Cov-2 Test Kits Manufacturing Sites, Area Served, Product Type
• 2.5 SARS-Cov-2 Test Kits Market Competitive Situation and Trends
• 2.5.1 SARS-Cov-2 Test Kits Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest SARS-Cov-2 Test Kits Players Market Share by Revenue

2.5.3 Global SARS-Cov-2 Test Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 SARS-Cov-2 Test Kits Retrospective Market Scenario by Region

• 3.1 Global SARS-Cov-2 Test Kits Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global SARS-Cov-2 Test Kits Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America SARS-Cov-2 Test Kits Market Facts & Figures by Country
• 3.3.1 North America SARS-Cov-2 Test Kits Sales by Country

3.3.2 North America SARS-Cov-2 Test Kits Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe SARS-Cov-2 Test Kits Market Facts & Figures by Country

3.4.1 Europe SARS-Cov-2 Test Kits Sales by Country

3.4.2 Europe SARS-Cov-2 Test Kits Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific SARS-Cov-2 Test Kits Market Facts & Figures by Region

3.5.1 Asia Pacific SARS-Cov-2 Test Kits Sales by Region

3.5.2 Asia Pacific SARS-Cov-2 Test Kits Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America SARS-Cov-2 Test Kits Market Facts & Figures by Country

3.6.1 Latin America SARS-Cov-2 Test Kits Sales by Country

3.6.2 Latin America SARS-Cov-2 Test Kits Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa SARS-Cov-2 Test Kits Market Facts & Figures by Country

3.7.1 Middle East and Africa SARS-Cov-2 Test Kits Sales by Country

3.7.2 Middle East and Africa SARS-Cov-2 Test Kits Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global SARS-Cov-2 Test Kits Historic Market Analysis by Type

• 4.1 Global SARS-Cov-2 Test Kits Sales Market Share by Type (2017-2022)
• 4.2 Global SARS-Cov-2 Test Kits Revenue Market Share by Type (2017-2022)
• 4.3 Global SARS-Cov-2 Test Kits Price by Type (2017-2022)

5 Global SARS-Cov-2 Test Kits Historic Market Analysis by Application

• 5.1 Global SARS-Cov-2 Test Kits Sales Market Share by Application (2017-2022)
• 5.2 Global SARS-Cov-2 Test Kits Revenue Market Share by Application (2017-2022)
• 5.3 Global SARS-Cov-2 Test Kits Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Thermo Fisher Scientific
• 6.1.1 Thermo Fisher Scientific Corporation Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Thermo Fisher Scientific SARS-Cov-2 Test Kits Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 EKF Diagnostics

6.2.1 EKF Diagnostics Corporation Information

6.2.2 EKF Diagnostics Description and Business Overview

6.2.3 EKF Diagnostics SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.2.4 EKF Diagnostics SARS-Cov-2 Test Kits Product Portfolio

6.2.5 EKF Diagnostics Recent Developments/Updates

6.3 Randox Laboratories Ltd

6.3.1 Randox Laboratories Ltd Corporation Information

6.3.2 Randox Laboratories Ltd Description and Business Overview

6.3.3 Randox Laboratories Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Randox Laboratories Ltd SARS-Cov-2 Test Kits Product Portfolio

6.3.5 Randox Laboratories Ltd Recent Developments/Updates

6.4 Fujirebio

6.4.1 Fujirebio Corporation Information

6.4.2 Fujirebio Description and Business Overview

6.4.3 Fujirebio SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Fujirebio SARS-Cov-2 Test Kits Product Portfolio

6.4.5 Fujirebio Recent Developments/Updates

6.5 EUROIMMUN Medizinische Labordiagnostika AG

6.5.1 EUROIMMUN Medizinische Labordiagnostika AG Corporation Information

6.5.2 EUROIMMUN Medizinische Labordiagnostika AG Description and Business Overview

6.5.3 EUROIMMUN Medizinische Labordiagnostika AG SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.5.4 EUROIMMUN Medizinische Labordiagnostika AG SARS-Cov-2 Test Kits Product Portfolio

6.5.5 EUROIMMUN Medizinische Labordiagnostika AG Recent Developments/Updates

6.6 Medcaptain Medical Technology Co., Ltd

6.6.1 Medcaptain Medical Technology Co., Ltd Corporation Information

6.6.2 Medcaptain Medical Technology Co., Ltd Description and Business Overview

6.6.3 Medcaptain Medical Technology Co., Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Medcaptain Medical Technology Co., Ltd SARS-Cov-2 Test Kits Product Portfolio

6.6.5 Medcaptain Medical Technology Co., Ltd Recent Developments/Updates

6.7 ADS Biotec

6.6.1 ADS Biotec Corporation Information

6.6.2 ADS Biotec Description and Business Overview

6.6.3 ADS Biotec SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.4.4 ADS Biotec SARS-Cov-2 Test Kits Product Portfolio

6.7.5 ADS Biotec Recent Developments/Updates

6.8 Hangzhou Matridx Biotechnology Co.,Ltd

6.8.1 Hangzhou Matridx Biotechnology Co.,Ltd Corporation Information

6.8.2 Hangzhou Matridx Biotechnology Co.,Ltd Description and Business Overview

6.8.3 Hangzhou Matridx Biotechnology Co.,Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Hangzhou Matridx Biotechnology Co.,Ltd SARS-Cov-2 Test Kits Product Portfolio

6.8.5 Hangzhou Matridx Biotechnology Co.,Ltd Recent Developments/Updates

6.9 TODA PHARMA

6.9.1 TODA PHARMA Corporation Information

6.9.2 TODA PHARMA Description and Business Overview

6.9.3 TODA PHARMA SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.9.4 TODA PHARMA SARS-Cov-2 Test Kits Product Portfolio

6.9.5 TODA PHARMA Recent Developments/Updates

6.10 Lepu Medical Technology(Beijing)Co.,Ltd

6.10.1 Lepu Medical Technology(Beijing)Co.,Ltd Corporation Information

6.10.2 Lepu Medical Technology(Beijing)Co.,Ltd Description and Business Overview

6.10.3 Lepu Medical Technology(Beijing)Co.,Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Lepu Medical Technology(Beijing)Co.,Ltd SARS-Cov-2 Test Kits Product Portfolio

6.10.5 Lepu Medical Technology(Beijing)Co.,Ltd Recent Developments/Updates

6.11 Peroxymed

6.11.1 Peroxymed Corporation Information

6.11.2 Peroxymed SARS-Cov-2 Test Kits Description and Business Overview

6.11.3 Peroxymed SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Peroxymed SARS-Cov-2 Test Kits Product Portfolio

6.11.5 Peroxymed Recent Developments/Updates

6.12 Nanjing Liming Bio-products Co., Ltd

6.12.1 Nanjing Liming Bio-products Co., Ltd Corporation Information

6.12.2 Nanjing Liming Bio-products Co., Ltd SARS-Cov-2 Test Kits Description and Business Overview

6.12.3 Nanjing Liming Bio-products Co., Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Nanjing Liming Bio-products Co., Ltd SARS-Cov-2 Test Kits Product Portfolio

6.12.5 Nanjing Liming Bio-products Co., Ltd Recent Developments/Updates

6.13 Tianjin Era Biology Techology Co., Ltd

6.13.1 Tianjin Era Biology Techology Co., Ltd Corporation Information

6.13.2 Tianjin Era Biology Techology Co., Ltd SARS-Cov-2 Test Kits Description and Business Overview

6.13.3 Tianjin Era Biology Techology Co., Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Tianjin Era Biology Techology Co., Ltd SARS-Cov-2 Test Kits Product Portfolio

6.13.5 Tianjin Era Biology Techology Co., Ltd Recent Developments/Updates

6.14 Shanghai Outdo Biotech Co., Ltd

6.14.1 Shanghai Outdo Biotech Co., Ltd Corporation Information

6.14.2 Shanghai Outdo Biotech Co., Ltd SARS-Cov-2 Test Kits Description and Business Overview

6.14.3 Shanghai Outdo Biotech Co., Ltd SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Shanghai Outdo Biotech Co., Ltd SARS-Cov-2 Test Kits Product Portfolio

6.14.5 Shanghai Outdo Biotech Co., Ltd Recent Developments/Updates

6.15 AiKang Medtech

6.15.1 AiKang Medtech Corporation Information

6.15.2 AiKang Medtech SARS-Cov-2 Test Kits Description and Business Overview

6.15.3 AiKang Medtech SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.15.4 AiKang Medtech SARS-Cov-2 Test Kits Product Portfolio

6.15.5 AiKang Medtech Recent Developments/Updates

6.16 Goldsite Diagnostics Inc.

6.16.1 Goldsite Diagnostics Inc. Corporation Information

6.16.2 Goldsite Diagnostics Inc. SARS-Cov-2 Test Kits Description and Business Overview

6.16.3 Goldsite Diagnostics Inc. SARS-Cov-2 Test Kits Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Goldsite Diagnostics Inc. SARS-Cov-2 Test Kits Product Portfolio

6.16.5 Goldsite Diagnostics Inc. Recent Developments/Updates

7 SARS-Cov-2 Test Kits Manufacturing Cost Analysis

• 7.1 SARS-Cov-2 Test Kits Key Raw Materials Analysis
• 7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of SARS-Cov-2 Test Kits

7.4 SARS-Cov-2 Test Kits Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 SARS-Cov-2 Test Kits Distributors List
• 8.3 SARS-Cov-2 Test Kits Customers

9 SARS-Cov-2 Test Kits Market Dynamics

• 9.1 SARS-Cov-2 Test Kits Industry Trends
• 9.2 SARS-Cov-2 Test Kits Market Drivers
• 9.3 SARS-Cov-2 Test Kits Market Challenges
• 9.4 SARS-Cov-2 Test Kits Market Restraints

10 Global Market Forecast

• 10.1 SARS-Cov-2 Test Kits Market Estimates and Projections by Type
• 10.1.1 Global Forecasted Sales of SARS-Cov-2 Test Kits by Type (2023-2028)

10.1.2 Global Forecasted Revenue of SARS-Cov-2 Test Kits by Type (2023-2028)

10.2 SARS-Cov-2 Test Kits Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of SARS-Cov-2 Test Kits by Application (2023-2028)

10.2.2 Global Forecasted Revenue of SARS-Cov-2 Test Kits by Application (2023-2028)

10.3 SARS-Cov-2 Test Kits Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of SARS-Cov-2 Test Kits by Region (2023-2028)

10.3.2 Global Forecasted Revenue of SARS-Cov-2 Test Kits by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
• 12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

Industry Insights
Due to the COVID-19 pandemic, the global SARS-Cov-2 Test Kits market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe SARS-Cov-2 Test Kits market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe SARS-Cov-2 Test Kits landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

IgM Test Kit accounting for % of the SARS-Cov-2 Test Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of SARS-Cov-2 Test Kits include Thermo Fisher Scientific, EKF Diagnostics, Randox Laboratories Ltd, Fujirebio, EUROIMMUN Medizinische Labordiagnostika AG, Medcaptain Medical Technology Co., Ltd, ADS Biotec, Hangzhou Matridx Biotechnology Co.,Ltd and TODA PHARMA, etc. In terms of revenue, the global 3 largest players have a % market share of SARS-Cov-2 Test Kits in 2021.

This report focuses on SARS-Cov-2 Test Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall SARS-Cov-2 Test Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the SARS-Cov-2 Test Kits market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

IgM Test Kit

IgG Test Kit

Segment by Application

Hospital

Clinic

Disease Control and Prevention System

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher Scientific

EKF Diagnostics

Randox Laboratories Ltd

Fujirebio

EUROIMMUN Medizinische Labordiagnostika AG

Medcaptain Medical Technology Co., Ltd

ADS Biotec

Hangzhou Matridx Biotechnology Co.,Ltd

TODA PHARMA

Lepu Medical Technology(Beijing)Co.,Ltd

Peroxymed

Nanjing Liming Bio-products Co., Ltd

Tianjin Era Biology Techology Co., Ltd

Shanghai Outdo Biotech Co., Ltd

AiKang Medtech

Goldsite Diagnostics Inc.

Frequently Asked Questions

Which product segment grabbed the largest share in the SARS-Cov-2 Test Kits market?

How is the competitive scenario of the SARS-Cov-2 Test Kits market?

Which are the key factors aiding the SARS-Cov-2 Test Kits market growth?

Which are the prominent players in the SARS-Cov-2 Test Kits market?

Which region holds the maximum share in the SARS-Cov-2 Test Kits market?

What will be the CAGR of the SARS-Cov-2 Test Kits market during the forecast period?

Which application segment emerged as the leading segment in the SARS-Cov-2 Test Kits market?

What key trends are likely to emerge in the SARS-Cov-2 Test Kits market in the coming years?

What will be the SARS-Cov-2 Test Kits market size by 2028?

Which company held the largest share in the SARS-Cov-2 Test Kits market?